Recurrent Pregnancy Loss
54
8
10
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.6%
3 terminated out of 54 trials
83.3%
-3.2% vs benchmark
7%
4 trials in Phase 3/4
13%
2 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (54)
Effects of High-frequency Left Dorsolateral Prefrontal rTMS on Heart-brain Coupling in Women With Recurrent Pregnancy Loss and Elevated BMI
Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss
Tender Loving Care for Recurrent Pregnancy Loss
High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety
Effect of Comprehensive Spa Rehabilitation on Female Infertility: A Clinical Study in Adult Women (Infertility-Spa)
Genomic Predictors of Recurrent Pregnancy Loss
Study of Endometrial Immune and Microbiological Modifications in Cases of Recurrent Implantation Failure and/or Recurrent Pregnancy Loss
Sperm DNA Fragmentation in Recurrent Pregnancy Loss
Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab
Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss
Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
Prospective Recurrent Pregnancy Loss Registry
Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
B-vitamin Levels and Adverse Pregnancy Outcomes
Hysteroscopic Septoplasty by Different Modalities
Biweekly Follow-Up and At-Home Ultrasound Reduce Anxiety in Women With Recurrent Pregnancy Loss
Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patients